34 results
424B5
FENC
Fennec Pharmaceuticals Inc
1 May 20
Prospectus supplement for primary offering
5:28pm
, the speed at which we can recruit patients to participate in testing our product candidate. We have experienced delays in some of our clinical trials … for PEDMARKTM, as well as:
our ability to design and successfully execute appropriate clinical trials;
our ability to recruit and enroll patients
424B5
7046q6vf3l islf5p6
29 Apr 20
Prospectus supplement for primary offering
4:48pm
424B3
tye94x
21 Apr 14
Prospectus supplement
12:00am
424B3
dejrntjlhsjn uj9s
4 Apr 13
Prospectus supplement
12:00am
POS AM
x88upb2j
1 Apr 13
Prospectus update (post-effective amendment)
12:00am
424B3
gzcpjdjhwzq9u6 9c8b0
14 Feb 11
Prospectus supplement
12:00am
S-1/A
5dnb96
9 Feb 11
IPO registration (amended)
12:00am